Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Figure 1: Subgroup Analysis of Adults with COVID-19 Dosed within 5 Days of Symptom Onset with COVID-19 Related Hospitalization or Death from Any Cause Through Day 28: EPIC-HR Among subjects who were SARS-CoV-2 seropositive at baseline, 1/490 (0.2%) PAXLOVID recipients versus 8/479 (1.7%) placebo recipients met the primary endpoint of COVID-19 related hospitalization or death from any cause through Day 28 [reduction relative to placebo -1.47% (-2.70%, -0.25%)]
Our experienced team focuses on delivering exceptional care and achieving the best outcomes for our clients
l-Cys forms disulfide bridges, which provide strength and rigidity to keratin
The menu changes every week so you never get bored
US$ 22.16
US$ 27.28
US$ 19.99
